Immunotherapy and Microbiota for Targeting of Liver Tumor-Initiating Stem-like Cells

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) remains one of the more incurable diseases. Thus, finding an HCC treatment is urgent for this unmet medical need. Immunotherapy is a break-through treatment that may help 15–20% of HCC patients. In this review, pharmacological and immune-therapeutical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Machida, Keigo, Tahara, Stanley M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139909/
https://www.ncbi.nlm.nih.gov/pubmed/35625986
http://dx.doi.org/10.3390/cancers14102381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139909/
https://www.ncbi.nlm.nih.gov/pubmed/35625986
http://dx.doi.org/10.3390/cancers14102381

Ejemplares similares